Delivery of Biologics Across the Blood–Brain Barrier with Molecular Trojan Horse Technology

@article{Pardridge2017DeliveryOB,
  title={Delivery of Biologics Across the Blood–Brain Barrier with Molecular Trojan Horse Technology},
  author={W. Pardridge},
  journal={BioDrugs},
  year={2017},
  volume={31},
  pages={503-519}
}
  • W. Pardridge
  • Published 2017
  • Medicine
  • BioDrugs
  • Biologics are potential new therapeutics for many diseases of the central nervous system. Biologics include recombinant lysosomal enzymes, neurotrophins, decoy receptors, and therapeutic antibodies. These are large molecule drugs that do not cross the blood–brain barrier (BBB). All classes of biologics have been tested, without success, in clinical trials of brain disease over the last 25 years. In none of these past clinical trials was the biologic re-engineered to enable transport across the… CONTINUE READING
    49 Citations

    Figures, Tables, and Topics from this paper

    Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
    • 22
    • PDF
    Strategies for Enhancing the Permeation of CNS-Active Drugs through the Blood-Brain Barrier: A Review
    • 18
    • PDF
    Envisioning the future of polymer therapeutics for brain disorders.
    • 4
    • PDF

    References

    SHOWING 1-10 OF 150 REFERENCES
    Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier.
    • 140
    Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
    • 182
    Targeted delivery of protein and gene medicines through the blood–brain barrier
    • W. Pardridge
    • Biology, Medicine
    • Clinical pharmacology and therapeutics
    • 2015
    • 73
    Drug Targeting of Erythropoietin Across the Primate Blood-Brain Barrier with an IgG Molecular Trojan Horse
    • 60
    • PDF
    AGT-181: expression in CHO cells and pharmacokinetics, safety, and plasma iduronidase enzyme activity in Rhesus monkeys.
    • 40
    Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies
    • 87
    • Highly Influential
    Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.
    • 142
    • PDF